CLINICAL_TRIALS
research
· 2026-03-27
Clinical Trial Update: Inflammatory Challenge in Human Aggression. [Phase 2]
Summary
Phase 2 clinical trial update exploring inflammatory challenge in intermittent explosive disorder; currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Ohio State University | Conditions: Intermittent Explosive Disorder | Phase 2 | Status: RECRUITING